Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 352Erstellt: 23. Oktober 2026

2,4-Dichloropyridine → Ethyl 2-[(4-chloro-2-pyridinyl)amino]-1,3-oxazole-5-carboxylate

https://huagongshe.com/de/reaction/352

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
Edukt2,4-DichloropyridineHCID 33515—
EduktEthyl 2-amino-1,3-oxazole-5-carboxylateHCID 5260193—
ReagenzCesium carbonateHCID 10796—
KatalysatorBis(dibenzylideneacetone)palladiumHCID 9811564—
KatalysatorDi-tert-butyl(2',4',6'-triisopropyl-3,6-dimethoxy-(1,1'-biphenyl)-2-yl)phosphineHCID 44233348—
Lösungsmittel1,4-DioxaneHCID 31275—
ProduktEthyl 2-[(4-chloro-2-pyridinyl)amino]-1,3-oxazole-5-carboxylateHCID 1015844990%

Reaktionsbedingungen

Temperatur160 °C

Reaktionsschritte

Objective: Series of experiments to optimise yield of the above coupled product. Pd2(dba)3 (22.89 mg, 0.025 mmol), di-tert- butyl(2',4',6'-triisopropyl-3,6-dimethoxybiphenyl-2-yl)phosphine (48.4 mg, 0.10 mmol), 2,4-dichloropyridine (148 mg, 1.00 mmol), cesium carbonate (651 mg, 2.00 mmol),ethyl 2-aminooxazole-5-carboxylate (156 mg, 1.00 mmol) and 4,4'-di-tert-butylbiphenyl (60 mg, 0.23 mmol) were added to an oven dried microwave vial, the vial was capped and placed under an inert atmosphere, dioxane (4 mL) was added and the resulting mixture was heated at 160 °C for 1 h by microwave irradiation under a nitrogen atmosphere. Crude LCMS shows a switch in regioselectivity, with the other isomer becoming the major product in 25% yield based on internal standard (note: this is a rough estimate as the U.V absorbance may be significantly different to the other regioisomer). The regioisomeric ratio is 1.7:1 and although the product was not formed in synthetically useful yields, it is an interesting result. Conclusion: Switch in regioselectivty with the change in ligand may be worth pursuing, although greater selectivity was seen for this prduct in the preceeding reaction.

Herkunft & Nachweise

Quelldatensatz750 AstraZeneca ELN dataset
ORD IDord-81c9dfb0f9224007985242064ea9e33c
Quellennotiz750 AstraZeneca ELN dataset